Scientific Abstracts
2014 ADA 74th Scientific Sessions
San Francisco, CA
June 13-17, 2014

Bedtime oral insulin lowers fasting blood glucose levels in T2DM patients


Improved oral insulin bioavailability when delivered in soft capsules

Comparative assessment of the glucose-lowering effect of multiple oral insulin (ORMD-0801) formulation variants in pigs 

 

Yale Diabetes Symposium
Yale University West Campus, CT 
May 14, 2014
Oral insulin capsules: Clinical Highlights

 

Diabetes Technology Society Meeting 2013
San Francisco, California
Oct 31-Nov2, 2013
A dose-response of blood glucose concentrations to orally delivered insulin in healthy subjects 
 

 

ADA 73rd Annual Scientific Sessions
Chicago, Illinois
June 21-25, 2013
Dose response to oral insulin capsules in fasting, healthy subjects 
 

 

Global Technology Community Diabetes Summit 2013

 

GTC Diabetes Summit 2013
April 29-30, 2013, Boston, MA
Oral insulin capsules towards management of Type 1 diabetes mellitus
 

 

European Atherosclerosis Society Congress
81st EAS Congress
June 2-5, 2013, Lyon, France
Decreased CRP levels  in response to a six-week, once-daily oral insulin regimen
 

 

ISA 2012
Sydney, Australia
March 25-29, 2012
Decreased CRP Levels in response to a six week, once-daily oral insulin regimen

 

ADA 72nd Annual Scientific Sessions
Philidelphia, Pennsylvania
June 8-12, 2012
Concomitant oral insulin and exenatide therapies significantly curb postprandial glucose excursions in pigs

 

12th Annual Diabetes Technology Society Meeting
Bethesda, MD
Nov 8-10, 2012
Concomitant oral and subcutaneous insulin therapy toward stabilization of uncontrolled Type 1 Diabetes Mellitus

 

ILAF Project
September 2011
A Model of Long Term Intestinal Access in the Pigs

 

Diabetes Technology Meeting 2011
San Francisco, California
October 27-29, 2011
Evaluation of the Safety and  Efficacy of Two Oral Insulin Formulations in Healthy Volunteers

 

ADA 70th Annual Scientific Sessions
Orlando, Florida
June 25-29, 2010
A Single-Blind, Two-Period Study to Assess the Safety and Pharmacodynamics of an Orally Delivered GLP-1 Analog (Exenadite) in Healthy Subjects

 

ADA 70th Annual Scientific Sessions
Orlando, Florida
June 25-29, 2010
Oral insulin: Type 1 Diabetes (T1DM) Patient Response Upon Preprandial Administration

 

Diabetes Technology Meeting 2010
Bethesda, Maryland
November 11-13, 2010
Extended exposure to an oral insulin formulation yields decreased insulin secretion in Type II diabetes subjects

 

ADA 69th Annual Scientific Sessions
New Orleans, LA
June 5-9, 2009
Open-Label Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin Formulation in Subjects with Type 2 Diabetes (T2DM)
9th Annual Meeting of Diabetes Technology Society
San Francisco, California
5-7th November, 2009
A novel GLP-1 Analog delivered orally reduces postprandial glucose excursions in a porcine model
8th Annual Meeting of Diabetes Technology Society
Bethesda, Maryland
November 13-15, 2008
Enteral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in Dogs
ADA 68th Annual Scientific Sessions
San Francisco, California
June 6-10, 2008
Pharmacokinetics (PK) and Pharmacodynamics (PD) of Oral Insulin in Healthy Subjects

 

44th Annual Meeting of the European Association for the Study of Diabetes (EASD)
Rome, Italy
September 7-11, 2008
Open Label Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Five Oral Insulin Formulations in Healthy Subjects
Press Center | Terms & Conditions | Privacy Statement Design and programming by BIGDESIGN Creative Agency | All rights reserved © 2009 Oramed